Quantcast

Latest Omeprazole Stories

2010-04-15 07:00:00

WOODCLIFF LAKE, N.J., April 15 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that the U.S. District Court for the District of Delaware has ruled in favor of Par in its challenge of the University of Missouri's patents relating to omeprazole/sodium bicarbonate capsules (20 mg/1.1 g and 40 mg/1.1 g) and powders for oral suspension (20 mg/1.68 g and 40 mg/1.68 g), which are listed in the Orange Book for Santarus's Zegerid® product....

2010-04-08 14:28:21

New research by the University of East Anglia (UEA) shows no risk in combining two commonly-prescribed treatments for patients at risk of heart attacks and strokes. Published this month in the journal Alimentary Pharmacology & Therapeutics, the study is the largest investigation yet into concerns of an adverse interaction between Proton Pump Inhibitors (PPIs) and the antiplatelet drug clopidogrel. The researchers analyzed data from 23 large randomized clinical trials involving more than...

2010-04-01 07:30:00

WHITEHOUSE STATION, N.J., April 1 /PRNewswire/ -- Merck & Co., Inc. announced that beginning today, ZEGERID OTC(TM) (omeprazole 20 mg/sodium bicarbonate 1100 mg capsules), a new over-the-counter (OTC) option for treating frequent heartburn without a prescription, will become available in drug stores, grocery stores, mass merchandisers and club stores nationwide. The only OTC proton pump inhibitor (PPI) product with two active ingredients, ZEGERID OTC delivers relief in a different way....

2010-03-18 07:59:00

ROCKVILLE, Md., March 15 /PRNewswire-USNewswire/ -- Heart patients who took a stomach acid-suppressing proton-pump inhibitor along with clopidogrel - a drug that prevents blood clots - were only half as likely to be hospitalized for upper digestive tract bleeding than those who used clopidogrel alone, according to a new study supported by HHS' Agency for Healthcare Research and Quality and the National Heart, Lung, and Blood Institute at the National Institutes of Health. The study also...

2010-03-12 11:42:00

Alerts patients, health care professionals to potential for reduced effectiveness SILVER SPRING, Md., March 12 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today added a boxed warning to the anti-blood clotting drug Plavix (clopidogrel), alerting patients and health care professionals that the drug can be less effective in people who cannot metabolize the drug to convert it to its active form. (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) Plavix...

2010-02-09 08:00:00

DEERFIELD, Ill., Feb. 9 /PRNewswire/ -- Takeda Global Research & Development Center, Inc., U.S., (TGRD U.S.) announced today that it has initiated a trial to study how dexlansoprazole and several other proton pump inhibitors (PPIs) affect the pharmacokinetics and pharmacodynamics of Plavix (clopidogrel bisulfate) in healthy subjects. Takeda has been evaluating all published data and communications from the U.S. Food and Drug Administration (FDA) regarding the potential risks associated...

2010-02-03 13:30:00

CINCINNATI, Feb. 3 /PRNewswire/ -- For the New Orleans Saints, this past season has been marked as the winningest in franchise history, with a first time trip to Super Bowl XLIV. The five players who provided quarterback DREW BREES (PURDUE) consistent and dependable blocking throughout the season will add another to their list of "firsts" today. The New Orleans Saints offensive line was the first to be honored and named winner of the Madden Most Valuable Protectors Award, presented by...

2010-01-25 07:00:00

NEW YORK, Jan. 25 /PRNewswire-Asia-FirstCall/ -- NeoStem, Inc. ("NeoStem" or the "Company") (NYSE Amex: NBS), an international biopharmaceutical company with operations in the U.S. and China, announced that it recently was advised that its Suzhou Erye Pharmaceutical subsidiary ("Erye") received approval as of November 6, 2009 from the State Food and Drug Administration (SFDA) in China to manufacture and sell omeprazole 20mg capsules. Omeprazole, a proton pump inhibitor (PPI), is the...

53e9c84fbe16946afaa08c02bda091c61
2009-12-29 13:26:22

For years, the two most prevalent strategies for treating chronic gastroesophogeal reflux disease "” commonly known as "Ëœacid reflux' "” have been prescription medications and surgery.  Now, after a more than decade-long study in Sweden, researchers say that while both forms of treatment can be successful, each comes with its own unique set of advantages and disadvantages. Acid reflux disease occurs when the acidic digestive fluids in the stomach are regurgitated...

2009-12-01 16:34:00

WHITEHOUSE STATION, N.J., Dec. 1 /PRNewswire/ -- Merck & Co., Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved ZEGERID OTC(TM) (omeprazole 20 mg/sodium bicarbonate 1100 mg capsules), for over-the-counter treatment of frequent heartburn. ZEGERID OTC will be marketed over-the-counter by Schering-Plough HealthCare Products, Inc., the consumer healthcare division of Merck & Co., Inc. Schering-Plough and Merck merged on November 3, 2009. ZEGERID OTC...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related